Carnitine palmitoyl transferases

The steps in the subsequent utilization of muscle LCFAs may be summarized as follows. The free fatty acids, liberated from triglycerides by a neutral triglyceride lipase, are activated to form acyl CoAs by the mediation of LCFAcyl-CoA synthetase which is situated on the outer mitochondrial membrane. The next step involves carnitine palmitoyl transferase I (CPT I, see Figure 9) which is also located on the outer mitochondrial membrane and catalyzes the transfer of LCFAcyl residues from CoA to carnitine (y-trimethyl-amino-P-hydroxybutyrate). LCFAcyl... 

Carnitine palmitoyl transferase (CPT) deficiencies are commonly associated with myoglobinuria after prolonged exercise typically patients are young men and... 

Carnitine acyltransfefase-I (CAT-1) and carnitine acyltran erase-2 (CAT-2) are also refened to as carnitine palmrtoyl transferase-1 (CPT-1) and carnitine palmitoyl transferase-2 (CPT-2). The carnitine transport system is most important for allowing long-chain fatty acids to enter into the mitochondria. 

Figure 7.11 Mechanism of transport of long-chain fatty adds across the inner mitochondrial membrane as fatty acyl carnitine. CRT is the abbreviation for carnitine palmitoyl transferase. CPT-I resides on the outer surface of the inner membrane, whereas CPT-II resides on the inner side of the inner membrane of the mitochondria. Transport across the inner membrane is achieved by a carrier protein known as a translocase. FACN - fatty acyl carnitine, CN - carnitine. Despite the name, CRT reacts with long-chain fatty acids other than palmitate. CN is transported out of the mitochondria by the same translocase.

In animals, the production of CO2 from [ Cjpalmitate or octanoate is not consistendy affected by riboflavin deficiency, possibly as a result of increased activity of carnitine palmitoyl transferase, which is more a response to food deprivation than to riboflavin deficiency. However, the production of C02 from [ C] adipic acid is significandy reduced, and responds rapidly (with some overshoot) to repletion with the vitamin. It has been suggested that the abiUty to metabolize a test dose of [ Cjadipic acid may provide a sensitive means of investigating ribodavin nutritional status in human beings (Bates, 1989, 1990). 

Fatty acids are activated on the outer mitochondrial membrane, whereas they are oxidized in the mitochondrial matrix. A special transport mechanism is needed to carry long-chain acyl CoA molecules across the inner mitochondrial membrane. Activated long-chain fatty acids are transported across the membrane by conjugating them to carnitine, a zwitterionic alcohol. The acyl group is transferred from the sulfur atom of CoA to the hydroxyl group of carnitine to form acyl carnitine. This reaction is catalyzed by carnitine acyltransferase I (also called carnitine palmitoyl transferase I), which is bound to the outer mitochondrial membrane. 

Malonyl CoA (-) carnitine palmitoyl transferase I (decreasing -oxidation). 

CPT-I deficiency (liver and muscle types) 255120 600528 601987 Carnitine palmitoyl transferase I <1 100,000 Liver disease, hypotonia, renal tubular acidosis AFLP... 

CPT-II deficiency 600649 600650 Carnitine palmitoyl transferase II <1 100,000 Cardiomyopathy, liver disease, congenital anomalies. Adult onset myopathy. ... 

J. D. McGarry, S. E. Mills, C. S. Long, and D.W. Foster, Observations on the affinity for carnitine and malonyl-CoA sensitivity of carnitine palmitoyl transferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat, Biochem J 214, 21-28 (1983). 

This hepatomegaly is correlated to PPARa activation of acyl-CoA oxidase (AOX), the first enzyme of peroxisomal /3-oxidation of fatty acids and a gene with a PPRE in its promoter region14. In addition, hepatic mitochondrial /3-oxidation and microsomal w-oxidation of fatty acids are increased, as a direct result of PPARa activation of mRNA of specific enzymes associated with these pathways (carnitine palmitoyl transferase I and cytochrome P4504A, respectively). Activation of fatty acid oxidation by these three pathways would lead to enhanced fatty acid oxidation, given the appropriate substrate. PPARa has also been shown to enhance delivery of fatty acids to the oxidizing systems (Fig. 3). 

A on the matrix side of the membrane. This reaction, which is catalyzed by carnitine acy[transferase II (carnitine palmitoyl transferase II), is simply the reverse of the reaction that takes place in the cytoplasm. The reaction is thermodynamically feasible because of the zwitterionic nature of carnitine The O-acyl link in carnitine has a high group-transfer potential, apparently because, being zwitterions, carnitine and its esters are solvated differently from most other alcohols and their esters. Finally, the translocase returns carnitine to the cytoplasmic side in exchange for an incoming acyl carnitine. 

Carnitine acyltransferase (also called carnitine palmitoyl transferase)... 

As noted above, there have been reports that link some cases of APLP with a defect in fatty acid metabolism in the fetus. These include fetal deficiencies of long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD), carnitine-palmitoyl transferase 1 (CPT 1), and medium chain acyl-coenzyme A dehydrogenase (MCAD). The mechanism by which defective fetal fatty acid oxidation causes maternal illness is not known. However, since the fetus uses primarily glucose metabolism for its energy needs, it is likely that toxic products from the placenta, which does use fatty acid oxidation, cause the maternal liver failure. 

Insulin- dependent diabetes mellitus Non insulin- dependent diabetes mellitus Carnitine palmitoyl transferase Intraperitoneal Intravenous... 

Carnitine palmitoyltransferase I (CPTI also called carnitine acyltransferase I, CATI), the enzyme that transfers long-chain fatty acyl groups from CoA to carnitine, is located on the outer mitochondrial membrane (Fig. 23.5). Fatty acylcamitine crosses the inner mitochondrial membrane with the aid of a translocase. The fatty acyl group is transferred back to CoA by a second enzyme, carnitine palmitoyl-transferase II (CPTII or CATII). The carnitine released in this reaction returns to the cytosolic side of the mitochondrial membrane by the same translocase that brings fatty acylcamitine to the matrix side. Long-chain fatty acyl CoA, now located within the mitochondrial matrix, is a substrate for (3-oxidation. 

Fig. 23.5. Transport of long-chain fatty acids into mitochondria. The fatty acyl CoA crosses the outer mitochondrial membrane. Carnitine pahnitoyl transferase I in the outer mitochondrial membrane transfers the fatty acyl group to carnitine and releases Co ASH. The fatty acyl carnitine is translocated into the mitochondrial matrix as carnitine moves out. Carnitine palmitoyl transferase II on the inner mitochondrial membrane transfers the fatty acyl group back to CoASH, to form fatty acyl CoA in the matrix.

Fig. 23.4. Structure of fatty acylcamitine. Carnitine palmitoyl transferases catalyze the reversible transfer of a long-chain fatty acyl group from the fatty acyl CoA to the hydroxyl group of carnitine. The atoms in the dashed box originate from the fatty acyl CoA.

Fatty acid transport proteins The mitochondrial and peroxisomal enzymes of fatty acid oxidation Carnitine palmitoyl transferase I HMG-CoA synthase Apoprotein Clll (suppression)... 

ACC-2 produces malonyl CoA, which inhibits carnitine palmitoyl transferase I, thereby blocking fatty acid entry into the mitochondria. Muscle also contains malonyl CoA decarboxylase, which catalyzes the conversion of malonyl CoA to acetyl CoA and carbon dioxide. Thus, both the synthesis and degradation of malonyl CoA is carefully regulated in muscle cells to balance glucose and fatty acid oxidation. Both allosteric and covalent means of regulation are employed. Citrate activates ACC-2, and phosphorylation of ACC-2 by the adenosine monophosphate (AMP)-activated protein kinase inhibits ACC-2 activity. Phosphorylation of malonyl CoA decarboxylase by the AMP-activated protein kinase activates the enzyme, further enhancing fatty acid oxidation when energy levels are low. 

Fatty acid uptake by muscle requires the participation of fatty acid-binding proteins and the usual enzymes of fatty acid oxidation. Fatty acyl-CoA uptake into the mitochondria is controlled by malonyl-CoA, which is produced by an isozyme of acetyl-coA carboxylase (ACC-2 the ACC-1 isozyme is found in liver and adipose tissue and is used for fatty acid biosynthesis). ACC-2 is inhibited by phosphorylation by the AMP-activated protein kinase (AMP-PK) such that when energy levels are low the levels of malonyl CoA will drop, allowing fatty acid oxidation by the mitochondria. In addition, muscle cells also contain the enzyme malonyl CoA decarboxylase, which is activated by phosphorylation by the AMP-PK. Malonyl CoA decarboxylase converts malonyl CoA to acetyl CoA, thereby relieving the inhibition of carnitine palmitoyl transferase I (CPT-I) and stimulating fatty acid oxidation (Fig. 47.5). Muscle cells do not synthesize fatty acids the presence of acetyl CoA carboxylase in muscle is exclusively for regulatory purposes. 

Fatty acid uptake into cardiac muscle is similar to that for other muscle cell types and requires fatty acid-binding proteins and carnitine palmitoyl transferase I for transfer into the mitochondria. Fatty acid oxidation in cardiac muscle cells is regulated by altering the activities of ACC-2 and malonyl CoA decarboxylase. 

---